Skip to main content
Skip to content
Case File
kaggle-ho-020088House Oversight

Scaramucci’s blocked White House appointment over Chinese‑linked business conflict

Scaramucci’s blocked White House appointment over Chinese‑linked business conflict The passage identifies a specific conflict‑of‑interest involving Anthony Scaramucci’s pending sale of his firm and a potential White House role that would require negotiations with an entity partially controlled by the Chinese government. It suggests a concrete line of inquiry—whether the Chinese‑linked entity received any preferential treatment or whether the ethics office’s objections were overridden—while providing names, dates (pre‑inauguration), and a policy mechanism (deferred capital‑gains program). The claim is not widely reported, giving moderate novelty, but the actors are high‑profile (President Trump, White House, Scaramucci, Gary Cohn). The controversy is significant but lacks hard evidence of wrongdoing, placing it in the moderate‑to‑strong lead range. Key insights: Scaramucci was offered the Director of the White House Office of Public Engagement shortly before the inauguration.; The White House ethics office objected because his business sale would take months and involved negotiations with a Chinese‑controlled entity.; Scaramucci sought a “certificate of divestiture” similar to Gary Cohn’s for Goldman stock sale.

Date
Unknown
Source
House Oversight
Reference
kaggle-ho-020088
Pages
1
Persons
0
Integrity
No Hash Available

Summary

Scaramucci’s blocked White House appointment over Chinese‑linked business conflict The passage identifies a specific conflict‑of‑interest involving Anthony Scaramucci’s pending sale of his firm and a potential White House role that would require negotiations with an entity partially controlled by the Chinese government. It suggests a concrete line of inquiry—whether the Chinese‑linked entity received any preferential treatment or whether the ethics office’s objections were overridden—while providing names, dates (pre‑inauguration), and a policy mechanism (deferred capital‑gains program). The claim is not widely reported, giving moderate novelty, but the actors are high‑profile (President Trump, White House, Scaramucci, Gary Cohn). The controversy is significant but lacks hard evidence of wrongdoing, placing it in the moderate‑to‑strong lead range. Key insights: Scaramucci was offered the Director of the White House Office of Public Engagement shortly before the inauguration.; The White House ethics office objected because his business sale would take months and involved negotiations with a Chinese‑controlled entity.; Scaramucci sought a “certificate of divestiture” similar to Gary Cohn’s for Goldman stock sale.

Tags

kagglehouse-oversightmedium-importancewhite-house-appointmentsconflict-of-interestchinaethicspolitical-fundraising
0Share
PostReddit

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.